| ₹ crore | Q1 FY27 | Q1 FY26 | Change |
|---|---|---|---|
| Revenue | 393 | 258 | +52.3% |
| EBITDA | 91.7 | 64.5 | +42.2% |
| EBITDA margin | 23.4% | 25.0% | −1.7 pts |
| Profit before tax | 61.2 | 58.7 | +4.3% |
| Net profit | 45.4 | 42.0 | +8.0% |
| EPS | ₹4.88 | ₹4.36 | +11.9% |
Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.
| Tap a line for its trend | Currentlast 12M | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 |
|---|
| 9,110 | — | — | — | — | |
| 221 | 221 | 436 | 113 | 37.4 | |
| — | — | 31.7 | 2.9 | 2.0 | |
| 253 | 253 | 0.0 | 83.1 | 264 | |
| 9,143 | — | — | — | — | |
| 1,334 | 1,207 | 880 | 671 | 372 | |
| — | +37.1% | +31.3% | +80.5% | — | |
| 310 | 292 | 220 | 180 | 105 | |
| 23.3% | 24.2% | 25.0% | 26.8% | 28.4% | |
| 209 | 204 | 163 | 151 | 92.7 | |
| 174 | 170 | 131 | 114 | 64.2 | |
| 13.1% | 14.1% | 14.8% | 17.1% | 17.3% | |
| ₹18.11 | ₹17.67 | ₹13.55 | ₹11.88 | ₹6.66 | |
| — | +30.5% | +14.0% | +78.4% | — | |
| — | 205 | 150 | −3.1 | 63.8 | |
| — | −317 | −311 | −93.4 | −19.8 | |
| −112 | −112 | −161 | −96.4 | 44.0 | |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
In ₹ Crore except Per Share 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Current/LTM TTM · last close | |
|---|---|---|---|---|---|---|
| Market Capitalization | — | — | — | — | 9,110.3 | |
| - Cash, Equiv & ST Investments | 37.4 | 112.7 | 435.9 | 221.1 | 221.1 | |
| + Minority Interest | 2.0 | 2.9 | 31.7 | — | — | |
| + Total Debt | 263.8 | 83.1 | 0.0 | 253.3 | 253.3 | |
| Enterprise Value | — | — | — | — | 9,142.5 | |
| Revenue | 371.5 | 670.5 | 880.5 | 1,207.2 | 1,334.1 | |
| Growth %, YoY | — | +80.5 | +31.3 | +37.1 | — | |
| EBITDA | 105.3 | 179.9 | 220.2 | 292.1 | 310.4 | |
| Margin % | 28.35 | 26.83 | 25.01 | 24.20 | 23.26 | |
| EBIT | 92.7 | 150.6 | 163.1 | 204.3 | 209.2 | |
| Net Income | 64.2 | 114.5 | 130.6 | 170.3 | 174.5 | |
| Margin % | 17.27 | 17.07 | 14.83 | 14.11 | 13.08 | |
| EPS, Adj (current shares) | 6.66 | 11.88 | 13.55 | 17.67 | 18.11 | |
| Growth %, YoY | — | +78.4 | +14.0 | +30.5 | — | |
| Cash from Operations | 63.8 | -3.1 | 149.6 | 204.5 | — | |
| Capital Expenditures | -19.8 | -93.4 | -310.8 | -316.5 | — | |
| Free Cash Flow | 44.0 | -96.4 | -161.2 | -112.0 | -112.0 | |
Prices at the 29 October 2026 close · figures from the company's filings with NSE
Yatharth Hospital & Trauma Care Services (NSE: YATHARTH) had a market capitalisation of ₹8,896 crore at the 29 October 2026 close (₹923.30 a share), a PE ratio of 49.9 on the last four quarters' profit and a price-to-book ratio of 4.92. In FY26 its consolidated net profit attributable to shareholders was ₹170 crore on revenue of ₹1,207 crore; in Q1 FY27 (April–June 2026) it was ₹47.1 crore, up 12.0% year on year. Its debt-to-equity ratio was 0.14 on 31 March 2026. Promoters held 55.80% of the shares on 30 September 2026.
Yatharth Hospital & Trauma Care Services' PE ratio is 49.9 at the 29 October 2026 close (₹923.30 a share): a market capitalisation of ₹8,896 crore divided by consolidated net profit attributable to shareholders of ₹178 crore over the last four quarters (Q2 FY26 to Q1 FY27). On FY26 net profit attributable to shareholders (₹170 crore) it is 52.2.
Yatharth Hospital & Trauma Care Services' price-to-book (PB) ratio is 4.92 at the 29 October 2026 close: a market capitalisation of ₹8,896 crore divided by shareholders' equity (book value) of ₹1,807 crore on 31 March 2026. That is a book value of ₹187.55 per share against a share price of ₹923.30.
Yatharth Hospital & Trauma Care Services' net worth — shareholders' equity in its consolidated balance sheet — was ₹1,807 crore on 31 March 2026, up 12.6% from ₹1,605 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹8,896 crore at the 29 October 2026 close.
Yatharth Hospital & Trauma Care Services' market capitalisation was ₹8,896 crore at the 29 October 2026 close: 9.64 crore shares at ₹923.30 each.
Yatharth Hospital & Trauma Care Services' debt-to-equity ratio was 0.14 on 31 March 2026: borrowings of ₹253 crore against total equity of ₹1,807 crore. A year earlier, on 31 March 2025, it was 0.00.
In 2026, Yatharth Hospital & Trauma Care Services has declared one dividend: ₹0.50 (interim) with record date 14 August 2026.
No. Yatharth Hospital & Trauma Care Services had borrowings of ₹253 crore on 31 March 2026 (consolidated balance sheet), a debt-to-equity ratio of 0.14. Its cash and current investments were ₹263 crore, so it held net cash of ₹10 crore.
Yatharth Hospital & Trauma Care Services' book value per share was ₹187.55 on 31 March 2026: shareholders' equity of ₹1,807 crore divided by the 9.64 crore shares in issue, up 12.6% from ₹166.62 a year earlier. The share price at the 29 October 2026 close was ₹923.30.
Yatharth Hospital & Trauma Care Services' dividend yield is 0.05% at the 29 October 2026 close: dividends of ₹0.50 a share that went ex-dividend in the 12 months before that day, divided by the share price of ₹923.30. They were ₹0.50 on 14 August 2026 (interim).
In FY26, Yatharth Hospital & Trauma Care Services' return on equity (ROE) was 10.0% and its return on capital employed (ROCE) was 10.9%. ROE is net profit attributable to shareholders divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was 10.5% and ROCE 12.6%.
On 30 September 2026, Yatharth Hospital & Trauma Care Services' shares were held by promoters 55.80%, foreign portfolio investors (FII/FPI) 7.05%, domestic institutions (DII) 10.94% (including mutual funds at 9.56%) and retail and other non-institutional investors 26.21%. Over the year, FII holding was up 0.55 percentage points from 6.50% and DII holding was up 2.24 percentage points from 8.70%.
Yatharth Hospital & Trauma Care Services' latest results are for Q1 FY27 (April–June 2026), filed on 10 August 2026: consolidated net profit attributable to shareholders ₹47.1 crore, up 12.0% from ₹42 crore in Q1 FY26; revenue from operations ₹393 crore, up 52.3% year on year.
Yatharth Hospital & Trauma Care Services' basic earnings per share (EPS) were ₹18.20 in FY26, against ₹14.72 in FY25. Over the last four quarters (Q2 FY26 to Q1 FY27) they add up to ₹18.80.
Promoters held 55.80% of Yatharth Hospital & Trauma Care Services on 30 September 2026, unchanged from the previous quarter and down 5.84 percentage points from 61.64% a year earlier, according to the shareholding pattern filed with NSE.
Yatharth Hospital & Trauma Care Services will announce its Q2 FY27 results (July–September 2026) on Tuesday, 3 November 2026, the date of the board meeting it has notified to the exchanges.
In FY26, Yatharth Hospital & Trauma Care Services generated ₹205 crore of cash from operations and spent ₹317 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of −₹112 crore. In FY25 it was −₹161 crore.
In FY26 (April 2025–March 2026), Yatharth Hospital & Trauma Care Services' consolidated net profit attributable to shareholders was ₹170 crore, up 30.5% from ₹131 crore in FY25, on revenue from operations of ₹1,207 crore (up 37.1%). Over three years, from FY23, net profit was up 165.4%.
At the 29 October 2026 closing prices, on FY26 net profit attributable to shareholders, Yatharth Hospital & Trauma Care Services' PE ratio is 52.2, the lowest of the four: Max Healthcare Institute 57.4, Global Health 62.8 and Fortis Healthcare 54.7, a peer average of 58.3. Each is the company's market capitalisation at that price divided by its FY26 net profit.
On FY26 consolidated figures, against Max Healthcare Institute, Global Health and Fortis Healthcare: Yatharth Hospital & Trauma Care Services' operating margin of 16.9% is the third highest of the four (Max Healthcare Institute 21.5%, Global Health 15.8%, Fortis Healthcare 17.9%; peer average 18.4%); its return on equity of 10.0% is the lowest of the four (Max Healthcare Institute 14.3%, Global Health 15.2%, Fortis Healthcare 11.1%; peer average 13.5%); its revenue growth over three years of 48.1% a year is the highest of the four (Max Healthcare Institute 22.4% a year, Global Health 17.9% a year, Fortis Healthcare 13.2% a year; peer average 17.8% a year).
In FY26, Yatharth Hospital & Trauma Care Services earned net profit attributable to shareholders of ₹170 crore on revenue of ₹1,207 crore, against ₹1,442 crore on ₹8,373 crore for Max Healthcare Institute. Yatharth Hospital & Trauma Care Services' operating margin was 16.9% (Max Healthcare Institute 21.5%) and its return on equity 10.0% (Max Healthcare Institute 14.3%). At the 29 October 2026 close, Yatharth Hospital & Trauma Care Services' market capitalisation was ₹8,896 crore against ₹82,837 crore for Max Healthcare Institute, and its PE ratio on FY26 profit 52.2 against 57.4.
From Yatharth Hospital & Trauma Care Services' own consolidated results, balance sheets and shareholding patterns filed with NSE, and NSE prices (the latest used here: the 29 October 2026 close). Ratios are calculated by Alphave from those filings as each answer describes.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.